Trial Details

TERMINATED
Basic Information
Clinical ID c3915
Identifier NCT01337609
Trial Title Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Major Depressive Disorder|Irritable Bowel Syndrome
Interventions DRUG: Ganeden BC30|OTHER: Placebo (sugar pill)|OTHER: Ganeden BC30, Placebo (sugar pill)
Participant Information
Sponsor Massachusetts General Hospital
City Burlington
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2011-06
Primary Completion Date 2012-02
Completion Date 2012-02